Psoriatic arthritis (PsA) screening is acceptable to patients with psoriasis whether they are diagnosed with PsA or not, according to a research letter published online Aug. 17 in the British Journal of Dermatology.
Sep 21, 2022
0
2
There seems to be a causal effect between inflammatory bowel disease and psoriasis and psoriatic arthritis, according to a study published online Sept. 14 in JAMA Dermatology.
Sep 14, 2022
0
10
About 250,000 people in Austria suffer from psoriasis. One third of them develop inflammation in their joints (psoriatic arthritis) as a result of the chronic skin condition. As part of a study, a MedUni Vienna research team ...
Jul 6, 2022
0
40
Diet is unlikely to make any difference to the progression of osteoarthritis and rheumatoid arthritis, finds a review of the existing scientific evidence, published in the open access journal RMD Open.
May 31, 2022
0
13
Candidate biomarkers for disease progression in psoriasis have been identified, according to a review published online April 28 in the British Journal of Dermatology.
May 20, 2022
0
12
There are many different types of arthritis, and diagnosing the exact type of inflammatory disease that is affecting a patient's joints is not always easy. In an interdisciplinary research project conducted at Friedrich–Alexander ...
May 3, 2022
0
31
People with psoriasis and psoriatic arthritis, collectively known as psoriatic disease, are more likely to develop cardiovascular disease than others in the general population. In a new study published in Arthritis & Rheumatology ...
Mar 9, 2022
0
5
A new study suggests that a single bout of exercise does not change the immune response to a coronavirus booster shot in people with rheumatic autoimmune diseases. The article is published ahead of print in the Journal of ...
Feb 21, 2022
0
4
(HealthDay)—A new nomogram may assess the risk for psoriatic arthritis (PsA) in patients with plaque psoriasis, according to a study published online Jan. 20 in the Frontiers in Immunology.
Feb 17, 2022
0
19
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
